The chronic fatigue syndrome: clinical-pathophysiological, diagnostic and differential-diagnostic aspects (the literature review and data of own observations). Part 2
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 3
Abstract
The chronic fatigue syndrome (CFS) is a pathological condition, the incidence of which is constantly increasing worldwide, but reliable therapeutic and prophylactic rehab programs have not been developed yet. The paper elucidates the literature data from domestic and foreign sources concerning current methods of prevention, treatment and rehabilitation of CFS patients, as well as attempts to outline possible perspectives in this direction. It is stated that the treatment and rehabilitation of CFS patients should be based on the use of nonmedicated complexes (minimizing risk factors, controlled physical activity, cognitive behavioral therapy, wellness nutrition), and medications (analgesics, antidepressants, activators of metabolism, immunoregulators and alternative medicine). The general treatment principles of patients with CFS according to the international practice have been presented. The main stage of treatment lasts for 12 weeks with the use of multicomponent pharmacologic agents of multidirectional metabolitotropic, immune-corrective action as the basic factors against the background of the abovementioned nondrug and drug approaches. Further stages of rehabilitation are planned in a personalized way, with account of risk factors, social support measures, training and motivation of patients to actively participate in the treatment process. Further stages of rehabilitation can take months and years. The complete recovery is observed not very often, but the longterm remissions are frequent, and CFS recurrence depends on the properly designed treatment programs and the degree of their implementation by the patients. The ways to improve the above methods for over the past 10 years have been shown, and possible prospects in the aspect of rehabilitation of such patients have been outlined. The anticipated changes can be predicted for the treatment paradigm of this disorder from symptomatic therapy to the pathogenetic approach. The syndrome of chronic fatigue is a complex pathological state that is difficult to be treated, and the existing treatment and prophylactic methods require further improvement.
Authors and Affiliations
O. I. Voloshyn, B. P. Seniuk, L. O. Voloshyna, V. P. Prysyazhnyuk
Keywords
Related Articles
- EP ID EP668868
- DOI 10.30978/UTJ2019-3-64
- Views 116
- Downloads 0
The pathogenetic role of large intestine dysbiosis in the pathogenesis of the mutually burdened non-alcoholic fatty liver disease and chronic kidney disease
Objective — to establish the probable influence of the microbial state of the colon cavity (MSCC) content on the degree of steatosis and liver fibrosis in patients with non-alcoholic steatohepatitis (NASH) with obesity,...
The effectiveness of differentiated therapy with renin-angiotensin-aldosterone blockers in patients with heart failure and type 2 diabetes mellitus
Objective — to evaluate the efficacy of differentiated therapy for ACE inhibitors and ARB II in patients with HFpEF and type 2 diabetes mellitus (DM 2), depending on the M235T polymorphism of the ATG gene. Materials and...
Age-related aspects of bone tissue condition at chronic pancreatitis
The fact that chronic pancreatitis (СP) affects mostly patients of employable age is one of the important factors of its social significance. Objective — to study the state of bone tissue of patients with СP of various a...
Predictors of cognitive impairment in patients with chronic heart failure and reduced left ventricular ejection fraction
Objective — to investigate the predictors of cognitive impairment (CI) in patients with CHF and reduced left ventricular ejection fraction of (rLVEF). Materials and methods. The examinations involved 124 patients with CH...
Macrophage migration inhibitory factor and acute myocardial infarction
Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine involved in the development of many acute and chronic inflammatory diseases, including cardiovascular diseases. A link between MIF a...